One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 175,000 shares of Roche Holding AG (NYSEARCA: RHHBY) on Thursday, as the share price of this fund traded down nearly 2% in the day’s session. However, the fund’s share price has greatly improved over the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 177,900 shares of Roche. At Thursday’s closing price, this would have valued this sale at roughly $9.0 million. This is only a small fraction of the total holdings. This fund is up 26% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | 1833HK | Ping An Healthcare and Technology | 524,000 |
ARKG | RHHBY | Roche | 177,900 |
ARKG | SRPT | Sarepta Therapeutics | 17,408 |
ARKG | PSTI | Pluristem Therapeutics | 7,224 |
ARKK | MCRB | Seres Therapeutics | 10,974 |
ARKK | NSTG | Nanostring Technologies | 47,361 |
ARKK | DOCU | Docsign | 51,743 |
ARKK | SQ | Square | 41,400 |
ARKQ | XONE | Exone | 59,797 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
No Commission Fees, No Minimums, No Velvet Ropes. (Sponsored)
Robinhood revolutionized commission free investing, and it continues to do so today. With a few simple taps you can trade stocks like Nvidia and Amazon, market beating mutual funds, and trade options with Robinhood Financial. FDIC insurance coverage is just another benefit.
And, you can buy and sell cryptocurrencies like Bitcoin (BTC), Ethereum (ETH), and Dogecoin (DOGE) with Robinhood Crypto.
Sign up today — click here to start your journey.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.